You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 270 No. 17, November 3, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the Clinical Center of the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dose-Intensive Therapy for Breast Cancer

Joyce A. O'Shaughnessy, MD; Kenneth H. Cowan, MD, PhD

JAMA. 1993;270(17):2089-2092.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASE

In 1988, a 38-year-old woman noticed progressive, symmetrical hardening of both breasts. Mammograms showed dense tissue bilaterally with no discrete masses and biopsies were unfortunately not recommended. In 1989, she developed lumbar back pain, and a complete blood cell count showed a hemoglobin level of 90 mg/L, a white blood cell count of 3.4x109/L, and a platelet count of 90x109/L. Her breast examination showed bilateral, diffuse denseness without skin involvement. Breast and bone marrow biopsies showed estrogen receptor-positive infiltrating ductal breast carcinoma metastatic to the bone marrow. She was treated with dose-intensive fluorouracil, leucovorin calcium, doxorubicin, and cyclophosphamide (FLAC) in combination with the hematopoietic growth factor, granulocyte-macrophage colony-stimulating factor (GMCSF). After two cycles of therapy, her back pain had disappeared and her blood cell counts normalized. After 10 cycles, her breast examination was normal, but repeat bone marrow examination showed a residual microscopic focus . . . [Full Text PDF of this Article]


Author Affiliations

From the Medical Breast Cancer Section, Medicine Branch, National Cancer Institute, Bethesda, Md.


Footnotes

Reprint requests to the Medical Breast Cancer Section, Medicine Branch, National Cancer Institute, Bldg 10, Room 12N226, National Institutes of Health, Bethesda, MD 20892 (Dr O'Shaughnessy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.